CD8A and melanoma: Surface markers, such as a programmed cell death protein 1 (PD-1) and CD137, have been proven to be able to identify melanoma-specific CD8 TILs.11,12 The CD8+CD137+ population is minority and largely confined to the CD8+PD-1+ TIL subset.